Invention Grant
- Patent Title: Relaxin proteins for use in the diagnosis, prevention or treatment of multiple sclerosis
- Patent Title (中): 用于诊断，预防或治疗多发性硬化症的松弛蛋白
-
Application No.: US14128919Application Date: 2012-06-25
-
Publication No.: US09561261B2Publication Date: 2017-02-07
- Inventor: Roy Garvin , Alasdair Burns
- Applicant: Roy Garvin , Alasdair Burns
- Applicant Address: GB Glasgow
- Assignee: BVBIOMED LTD.
- Current Assignee: BVBIOMED LTD.
- Current Assignee Address: GB Glasgow
- Agency: Hoxie & Associates LLC
- Priority: GB1110833.9 20110624
- International Application: PCT/EP2012/062255 WO 20120625
- International Announcement: WO2012/175744 WO 20121227
- Main IPC: A61K38/22
- IPC: A61K38/22 ; C12Q1/68 ; G01N33/74
Abstract:
The present invention relates to the use of one or more Relaxin proteins in methods for diagnoses and treatment of multiple sclerosis. The invention also provides compositions for use in diagnosing or treating multiple sclerosis as well as the methods themselves. Kits for carrying out the methods are also described.
Public/Granted literature
- US20140256633A1 Relaxin Proteins For Use In The Diagnosis, Prevention or Treatment of Multiple Sclerosis Public/Granted day:2014-09-11
Information query
IPC分类:
